Affinity Asset Advisors, LLC New Holdings in Q3 2024

Affinity Asset Advisors, LLC

  • $579 Million
  • Q3 2024
Stock Shares change Price Range Shares Held Trade History
ARVN
Arvinas, Inc.

Healthcare
225K
New
$23.66 - $32.73 $5.32M - $7.36M
225K $5.54M
TERN
Terns Pharmaceuticals, Inc.

Healthcare
600K
New
$6.49 - $10.8 $3.89M - $6.48M
600K $5M
BMRN
Biomarin Pharmaceutical Inc

Healthcare
15K
New
$69.02 - $93.84 $1.04M - $1.41M
15K $1.05M
RPTX
Repare Therapeutics Inc.

Healthcare
173K
New
$2.75 - $3.99 $477K - $692K
173K $596K
VYGR
Voyager Therapeutics, Inc.

Healthcare
51.7K
New
$5.77 - $9.27 $298K - $480K
51.7K $302K
AADI
Aadi Bioscience, Inc.

Healthcare
47K
New
$1.32 - $2.06 $62.1K - $96.9K
47K $96K
Oruka Therapeutics Inc
350K
New
N/A
350K $0
Soleno Therapeutics Inc
25K
New
N/A
25K $0
Adagio Med Hldgs Inc
213K
New
N/A
213K $0
Travere Therapeutics Inc
5M
New
N/A
5M $0
Activity Summary
Buys All Purchases 34 New Holdings 11 Increased Positions 23 Sells All Sells 28 Reductions 28 Sold out 0 Options Calls 5 Puts 4
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email